| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 51.7851 | 53 |
| GSM780708 | Untreated after 4 days (C2_1) | 57.85 | 63 |
| GSM780709 | Untreated after 4 days (C3_1) | 42.0563 | 13 |
| GSM780719 | Untreated after 4 days (C1_2) | 53.968 | 58 |
| GSM780720 | Untreated after 4 days (C2_2) | 54.7622 | 59 |
| GSM780721 | Untreated after 4 days (C3_2) | 51.3796 | 52 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 53.3186 | 57 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 44.9519 | 27 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 49.5659 | 47 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 41.3817 | 11 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 44.9723 | 27 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 46.7379 | 36 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 50.3954 | 50 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 51.8735 | 54 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 55.5717 | 60 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 57.6734 | 63 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 56.4287 | 61 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 43.0133 | 17 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 40.7953 | 9 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 60.2894 | 65 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 61.286 | 65 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 44.0975 | 23 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 64.6814 | 67 |